A Study of the Safety and Effects of ADH-1 Given Daily to Subjects With Solid Tumors
Clinical trial NCT00225550 · TERMINATED
Trial details
- NCT number
- NCT00225550
- Sponsor
- Adherex Technologies, Inc.
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.